Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 22Breast 20Other hematologic neoplasm 16Tumor-Agnostic 13Gynecologic 10Genitourinary 10Thoracic 9Lymphoid 8CNS 7Other solid neoplasm 6Plasma cell 5Head & Neck 5Sarcoma 3Myeloid 3Endocrine 2Dermatologic 2Other 1NET 1

Conditions

Weight Loss 1Obesity 1Neuroendocrine Tumors 1Multiple Endocrine Neoplasia Type 1 1

Interventions

lutetium Lu 177 dotatate 36Everolimus 32pembrolizumab 24Temozolomide 21Magnetic Resonance Spectroscopy 21Nivolumab 18lenvatinib 17gallium Ga 68 dotatate 16cabozantinib 15Cisplatin 15lanreotide 143-Iodobenzylguanidine 14Capecitabine 13trametinib 12dabrafenib 12Bevacizumab 12Octreotide 11Surveys and Questionnaires 10Surgical Procedures, Operative 10Sunitinib 10Radiosurgery 10Positron Emission Tomography Computed Tomography 10Blood Specimen Collection 10Sorafenib 9Paclitaxel 9Ipilimumab 9Carboplatin 9surufatinib 8Etoposide 8Doxorubicin 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Palliative Care × Endocrine × Clear all
NCT01849523 2024-05-06

WIN

University Medical Center Groningen

Phase NA Completed
20 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT02938897 2016-10-19

Telenutrition Weight Loss Study for Men

West Virginia University

Phase NA Completed
60 enrolled
EndocrineOther

Obesity, Weight Loss, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡